These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 25941261)

  • 1. Can reporting of adverse drug reactions create safer systems while improving health data?
    Hohl C; Lexchin JR; Balka E
    CMAJ; 2015 Aug; 187(11):789-790. PubMed ID: 25941261
    [No Abstract]   [Full Text] [Related]  

  • 2. Towards Drug Safety Surveillance and Pharmacovigilance: Current Progress in Detecting Medication and Adverse Drug Events from Electronic Health Records.
    Liu F; Jagannatha A; Yu H
    Drug Saf; 2019 Jan; 42(1):95-97. PubMed ID: 30649734
    [No Abstract]   [Full Text] [Related]  

  • 3. Report of Adverse Events in Colombia: A Successful Case.
    Moreno-Mattar O; Ramírez R; Alvarado A; Sierra F; Guzmán J
    Curr Drug Saf; 2019; 14(1):53-56. PubMed ID: 30411692
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Viscerotropic disease: case definition and guidelines for collection, analysis, and presentation of immunization safety data.
    Gershman MD; Staples JE; Bentsi-Enchill AD; Breugelmans JG; Brito GS; Camacho LA; Cottin P; Domingo C; Durbin A; Gascon J; Guenaneche F; Hayes EB; Jelenik Z; Khromava A; Martins Rde M; Wilson MM; Massy N; Nasidi A; Niedrig M; Sherwat A; Tsai T; Vilella A; Wilson ME; Kohl KS;
    Vaccine; 2012 Jul; 30(33):5038-58. PubMed ID: 22561144
    [No Abstract]   [Full Text] [Related]  

  • 5. Re: adverse drug reactions in older patients during hospitalisation: are they predictable?
    Griebling T
    J Urol; 2013 Aug; 190(2):623. PubMed ID: 23845357
    [No Abstract]   [Full Text] [Related]  

  • 6. Effect of reporting bias in the analysis of spontaneous reporting data.
    Ghosh P; Dewanji A
    Pharm Stat; 2015; 14(1):20-5. PubMed ID: 25376637
    [TBL] [Abstract][Full Text] [Related]  

  • 7. How to Investigate a Serious Adverse Event Reported During a Clinical Trial for a COVID-19 Vaccine.
    Shakir S; Lane S; Davies M
    Drug Saf; 2021 Jan; 44(1):1-5. PubMed ID: 33219926
    [No Abstract]   [Full Text] [Related]  

  • 8. Detecting Adverse Drug Events: Accuracy and Generalizability.
    Walter SR; Gallego B
    Ther Innov Regul Sci; 2019 Nov; 53(6):795-796. PubMed ID: 30595045
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Minimising harm: human variation and adverse drug reactions (ADRs).
    Ritter JM
    Br J Clin Pharmacol; 2008 Apr; 65(4):451-2. PubMed ID: 18333858
    [No Abstract]   [Full Text] [Related]  

  • 10. The class imbalance problem detecting adverse drug reactions in electronic health records.
    Santiso S; Casillas A; Pérez A
    Health Informatics J; 2019 Dec; 25(4):1768-1778. PubMed ID: 30230408
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An Evaluation of Indian Consumers' Reporting of Suspected Adverse Drug Reactions with a Designated Reporting Form.
    Rehan HS; Sah R; Gupta A; Nagar P
    Curr Drug Saf; 2017; 12(1):51-56. PubMed ID: 27188794
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Drug-drug interactions and adverse drug reactions: separating the wheat from the chaff.
    Pirmohamed M
    Wien Klin Wochenschr; 2010 Feb; 122(3-4):62-4. PubMed ID: 20213370
    [No Abstract]   [Full Text] [Related]  

  • 13. Evaluation of patient reporting of adverse drug reactions to the UK 'Yellow Card Scheme': literature review, descriptive and qualitative analyses, and questionnaire surveys.
    Avery AJ; Anderson C; Bond CM; Fortnum H; Gifford A; Hannaford PC; Hazell L; Krska J; Lee AJ; McLernon DJ; Murphy E; Shakir S; Watson MC
    Health Technol Assess; 2011 May; 15(20):1-234, iii-iv. PubMed ID: 21545758
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Statistical methods for the analysis of adverse event data.
    Kieser M
    Pharm Stat; 2016 Jul; 15(4):290-1. PubMed ID: 27324410
    [No Abstract]   [Full Text] [Related]  

  • 15. Quality of case reports of adverse drug reactions with psychotropic drugs: a 25-year review.
    Talat B; Mayers A; Baldwin DS
    Hum Psychopharmacol; 2013 Sep; 28(5):413-20. PubMed ID: 23754771
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Africa struggles to improve drug safety.
    Appiah B
    CMAJ; 2012 Jul; 184(10):E533-4. PubMed ID: 22690007
    [No Abstract]   [Full Text] [Related]  

  • 17. Pharmacovigilance in Europe.
    Johnson CL; Hutchinson JA
    Transplantation; 2015 Aug; 99(8):1542-3. PubMed ID: 26308299
    [No Abstract]   [Full Text] [Related]  

  • 18. A cross-sectional study of adverse drug reactions reporting among doctors of a private medical college in Bihar, India.
    Panja B; Bhowmick S; Chowrasia VR; Bhattacharya S; Chatterjee RN; Sen A; Sarkar M; Ram AK; Mukherjee PK
    Indian J Pharmacol; 2015; 47(1):126-7. PubMed ID: 25821329
    [No Abstract]   [Full Text] [Related]  

  • 19. Fifty years of pharmacovigilance - Medicines safety and public health.
    Laporte JR
    Pharmacoepidemiol Drug Saf; 2016 Jun; 25(6):725-32. PubMed ID: 26799344
    [No Abstract]   [Full Text] [Related]  

  • 20. IOM: overhaul drug safety monitoring.
    Kuehn BM
    JAMA; 2006 Nov; 296(17):2075-6. PubMed ID: 17077364
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.